Lexidronam is a phosphonate analog of ethylenediaminetetraacetic acid (EDTA) with chelating activity. It binds to hydroxyapatite crystals in areas of bone turnover and has been used as a radiopharmaceutical in complexes with radioactive metals to selectively target osteoblastic bone metastases.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1429-50-1
Diethylenetriamine pentamethylene phosphonic acid
Industrial chelating agent
Aminotris(methylenephosphonic acid)
chelating agent
(((2-hydroxyethyl)imino)dimethylene)diphosphonic acid
chelating agent in industrial applications
1-decanethiol
chemical intermediate and research reagent
1-bromododecane
Alkylating agent for lipophilicity modification
Triethylene glycol monobutyl ether
Solvent, plasticizer, and metal degreasing agent
Tetraglyme
Solvent and lubricating agent
Lexidronam pentasodium
pharmaceutical raw material
[2-[bis(phosphonomethyl)amino]ethyl-(phosphonomethyl)amino]methylphosphonic acid
NFDRPXJGHKJRLJ-UHFFFAOYSA-N
C(CN(CP(=O)(O)O)CP(=O)(O)O)N(CP(=O)(O)O)CP(=O)(O)O